alicaforsen

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1997-2017
02419972017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
BACKGROUND AND AIMS The published data about the efficacy of the intercellular adhesion molecule-1 (ICAM-1) antisense… (More)
Is this relevant?
2013
2013
BACKGROUND The antisense ICAM-1 inhibitor alicaforsen has been studied in four phase 2 studies in ulcerative colitis (UC… (More)
Is this relevant?
2007
2007
BACKGROUND & AIMS The aim of this study was to compare the safety and efficacy of alicaforsen, a first-generation antisense… (More)
Is this relevant?
2006
2006
BACKGROUND Alicaforsen is a phosphorothioate-modified antisense oligodeoxynucleotide designed to sequence-specifically reduce… (More)
Is this relevant?
Review
2005
Review
2005
Isis is developing alicaforsen, an RNase H-dependent antisense inhibitor of intercellular adhesion molecule-1, for the potential… (More)
Is this relevant?
2004
2004
BACKGROUND Pouchitis is the major long-term complication of ileal pouch-anal anastomosis for ulcerative colitis. The incidence of… (More)
Is this relevant?
2004
2004
Objective: To evaluate the safety and efficacy of an enema formulation of alicaforsen, an antisense inhibitor of intercellular… (More)
  • table 2
  • table 1
  • figure 1
  • figure 2
  • figure 1
Is this relevant?
2002
2002
BACKGROUND AND AIMS To evaluate the safety and efficacy of the intercellular adhesion molecule 1 (ICAM-1) antisense… (More)
Is this relevant?
2002
2002
BACKGROUND AND AIMS To evaluate the safety, pharmacokinetics and clinical efficacy of the intercellular adhesion molecule-1… (More)
Is this relevant?
Review
2001
Review
2001
Alicaforsen (ISIS-2302) is an RNase H-dependent antisense inhibitor of the intercellular adhesion molecule ICAM-1 under… (More)
Is this relevant?